Tell me about yourself and the company.
I’m an internist and infectious diseases doctor with a PhD in virology, a serial entrepreneur, and a venture capitalist. During my career, I’ve developed deep expertise in biotechnology, biopharmaceuticals, specialty medical products, and healthcare innovation. I’ve participated in the development of over 15 top-selling drugs, biologics, diagnostics, imaging agents, and medical devices. Additionally, philanthropy and mentoring are a very important part of my life. I actively advise and sponsor entrepreneurial programs and innovation funds at leading institutions like the University of Chicago, Wharton, Johns Hopkins, USC, the University of Texas, and Houston Methodist Research Institute. I also assist leading universities on the public health front, and serve as an advisor to the Harvard School of Public Health and the Johns Hopkins Bloomberg School of Public Health.

Health2047, whose founding partner is the AMA, is an entirely new business model in the healthcare industry — an integrated innovation company —that will work with both established players and early-stage growth companies. It combines strategy, engineering, design, and venture disciplines to create new and important linkages between the physician community and the AMA’s content/regulatory experts with leading companies, emerging companies, and individual entrepreneurs. Bottom line: Health2047 is in business to develop, optimize, and harvest disruptive ideas that enhance — at the system level — the practice of US healthcare…